Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Bekeken
• 08/09/23
0
0
insluiten
administrator
abonnees
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties